|1.||Ginesta, Mireia M: 1 article (03/2003)|
|2.||Ribas, Yolanda: 1 article (03/2003)|
|3.||Mestre, Mariona: 1 article (03/2003)|
|4.||Mollevi, David G: 1 article (03/2003)|
|5.||Jaurrieta, Eduardo: 1 article (03/2003)|
|6.||Serrano, Teresa: 1 article (03/2003)|
|7.||Figueras, Joan: 1 article (03/2003)|
|8.||Bas, Jordi: 1 article (03/2003)|
|9.||Herrero-Fresneda, I: 1 article (04/2001)|
|10.||Cruzado, J M: 1 article (04/2001)|
|1.||Acute Kidney Injury (Acute Renal Failure)
04/01/2001 - "The chronic administration of the PAF antagonist UR-12670 attenuates the long-term effects of ischaemia-reperfusion injury in uninephrectomized ageing rats. "
11/01/1999 - "The chronic administration of the PAF antagonist UR-12670 attenuates the long-term effects of ischemia-reperfusion injury in uninephrectomized rats. "
01/01/1997 - "UR-12670 protected against several shock symptoms, confirming the role of PAF in the pathogenesis of rodent endotoxemia."
01/01/1997 - "UR-12670 is a novel and potent PAF antagonist, eg., it displaces [3H]WEB-2086 from PAF receptors in rabbit platelet membranes (Ki = 0.6 nM) and inhibits PAF-induced increase in vascular permeability in rat trachea (100%), thymus (44%), seminal vesicles (100%) and stomach (54%) at a dose of 0.01 mg/kg i.v. Since PAF is thought to be an important mediator in endotoxic shock, the effect of pretreatment with UR-12670 on changes in vascular permeability, disseminated intravascular coagulation (DIC) and plasma biochemical parameters were determined in a rat model of acute endotoxemia. "
|1.||Platelet Activating Factor
|3.||WEB 2086 (apafant)
|4.||platelet activating factor receptor
|1.||Heterologous Transplantation (Xenotransplantation)